Original Investigation

Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression

JAMA Network Open 10.1001/jamanetworkopen.2026.12589

May 15, 2026 at 11:00 AM EDT

Read the full article

Does a single dose of psilocybin have short- and long-term antidepressant effects on patients with recurrent major depressive disorder?In this randomized clinical trial of 35 participants, a single 25-mg dose of psilocybin produced a significantly greater reduction in depressive symptoms compared with 100 mg of niacin according to the Montgomery-Åsberg Depression Rating Scale score on day 8. The duration of effect was more than 3 months.This study’s findings suggest that psilocybin may provide a rapid and relatively long-lasting antidepressant effect on major depressive disorder, warranting further investigation into repeated dosing or adjunctive treatment strategies.

Corresponding Author: Hampus Yngwe, MD, MSc, Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, BioClinicum J4, Akademiska Stråket 1, SE-17164 Stockholm, Sweden (hampus.yngwe@ki.se).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks